Primary Biliary Cholangitis Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been officially diagnosed with Primary Biliary Cholangitis (PBC), a liver condition.
- You are 18 years of age or older.
- You are currently taking a medication called ursodiol (also known as ursodeoxycholic acid) for PBC, or you cannot tolerate this medication due to side effects and have an elevated liver enzyme level (ALP) above the normal range.
- You are currently being treated with a medication called seladelpar for PBC.
- You are willing and able to sign a consent form agreeing to take part in the study.
Who may not be able to join:
- You have another ongoing liver disease, such as hepatitis B, hepatitis C, a liver condition related to fat buildup (NASH), liver disease caused by alcohol use, or another autoimmune liver disease.
- You have previously had a liver transplant.
- You currently have cirrhosis (severe liver scarring) or signs that your liver is no longer working properly (confirm with trial site).
- You have serious other health conditions, such as severe heart, kidney, or lung disease, that could affect the study results.
- You are currently pregnant or breastfeeding.
- You are unwilling or unable to follow the study plan, including attending scheduled appointments and completing required tests and procedures.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mangesh Pagadala, MD, Methodist Heath System
Phone: 7373332427
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
ALP and bilirubin levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.